Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave P Nichols

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 7, 2020
Early Aspergillosis in Cystic Fibrosis and Air Trapping: Guilt by Association?Dave P Nichols, Richard B Moss
American Journal of Respiratory and Critical Care Medicine|November 14, 2018
Developmental Milestones in Pediatric Research: A Case for Including Efficacy as Part of Interventional Trials in Infants with Cystic FibrosisDon B Sanders, Dave P Nichols
Expert Opinion on Investigational Drugs|August 4, 2020
Cystic fibrosis - Ten promising therapeutic approaches in the current era of careRanjani Somayaji, Dave P Nichols, Scott C Bell
Annals of the American Thoracic Society|January 19, 2019
Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and OpportunitiesDave P Nichols, Anthony G Durmowicz, Ann Field, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 28, 2020
Long-term azithromycin use is not associated with QT prolongation in children with cystic fibrosisAmalia S Magaret, Jack Salerno, Jason F Deen, et al.
American Journal of Respiratory and Critical Care Medicine|October 30, 2019
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic FibrosisDave P Nichols, Katherine Odem-Davis, Jonathan D Cogen, et al.
Annals of the American Thoracic Society|March 7, 2019
Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic FibrosisRanjani Somayaji, Renee Russell, Jonathan D Cogen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 28, 2016
Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosisDave P Nichols, Carrie L Happoldt, Preston E Bratcher, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 23, 2021
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapyDave P Nichols, Scott H Donaldson, Carla A Frederick, et al.
The Journal of Experimental Medicine|June 14, 2017
Recurrent rhinovirus infections in a child with inherited MDA5 deficiencyIan T Lamborn, Huie Jing, Yu Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Respiratory and Critical Care Medicine|January 7, 2020
Early Aspergillosis in Cystic Fibrosis and Air Trapping: Guilt by Association?Dave P Nichols, Richard B Moss
American Journal of Respiratory and Critical Care Medicine|November 14, 2018
Developmental Milestones in Pediatric Research: A Case for Including Efficacy as Part of Interventional Trials in Infants with Cystic FibrosisDon B Sanders, Dave P Nichols
Expert Opinion on Investigational Drugs|August 4, 2020
Cystic fibrosis - Ten promising therapeutic approaches in the current era of careRanjani Somayaji, Dave P Nichols, Scott C Bell
Annals of the American Thoracic Society|January 19, 2019
Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and OpportunitiesDave P Nichols, Anthony G Durmowicz, Ann Field, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 28, 2020
Long-term azithromycin use is not associated with QT prolongation in children with cystic fibrosisAmalia S Magaret, Jack Salerno, Jason F Deen, et al.
American Journal of Respiratory and Critical Care Medicine|October 30, 2019
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic FibrosisDave P Nichols, Katherine Odem-Davis, Jonathan D Cogen, et al.
Annals of the American Thoracic Society|March 7, 2019
Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic FibrosisRanjani Somayaji, Renee Russell, Jonathan D Cogen, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 28, 2016
Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosisDave P Nichols, Carrie L Happoldt, Preston E Bratcher, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 23, 2021
PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapyDave P Nichols, Scott H Donaldson, Carla A Frederick, et al.
The Journal of Experimental Medicine|June 14, 2017
Recurrent rhinovirus infections in a child with inherited MDA5 deficiencyIan T Lamborn, Huie Jing, Yu Zhang, et al.
Pageof 1